• In patients with AF, warfarin was associated with higher rates of major bleeding compared with rivaroxaban. Associations became nonsignificant when adjusted for age, Charlson score, and CHA2DS2-VASc score
    • According to the perceived risk, the authors suggest individual HCP bias for selecting a given OAC